MedTrace Logo

CGM Use in Children With Type 2 Diabetes

NCT04721158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2023-09-15

Study results available
· View outcomes & findings →

Summary

The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.

Conditions

Interventions

DEVICE

Continuous glucose monitor

Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.

Sponsors & Collaborators

Principal Investigators

  • Risa M Wolf, MD · Johns Hopkins School of Medicine

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-17
Primary Completion
2022-07-28
Completion
2022-07-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04721158 on ClinicalTrials.gov